Communities of practice |
Renewed rabies vigilance needed in China25 Sep 2008 Paul Chinnock
Source: BMC Infectious Diseases
(see original article Citation: Si H, Guo ZM, Hao YT, Liu YG, Zhang DM, Rao SQ, Lu JH (2008). Renewed rabies vigilance needed in China. BMC Infect Dis; 8:113. Rabies is a major public-health problem in many developing countries. In China, however, the disease in humans was largely brought under control in the period 1990–1996, owing to nationwide rabies vaccination programmes. An extensive dog vaccination programme was also initiated. More recently, there have been reports of an increased number of cases. The situation was therefore examined in a study by Guo et al. The authors analysed epidemiological data for 22527 human rabies cases from January 1990 to July 2007, retrieved from the surveillance database of reportable diseases managed by the Ministry of Health of China. To investigate the efficiency of the post-exposure (PEP) treatment of rabies, the details of 244 rabies patients, including their anti-rabies treatment of injuries or related incidents, were ascertained from one provincial jurisdiction. The analysis found that incidence rates were below 0.05 per 100,000 people between 1994 and 2000, but there was then a large jump in the number of reported cases up to a new peak (with an incidence rate of 0.20 per 100,000) that was reached in 2004, and where the level has remained until present. Analysis of the PEP in 244 cases found that 67.2% of patients did not seek medical services or did not receive any PEP. Further analysis of the 80 rabies patients who did receive any type of PEP indicated that almost all of them had not been given proper or timely treatment of their wounds, or post-exposure vaccination or rabies immunoglobulins. In their conclusions, the study authors note that the issue of under-reporting of rabies in previous years may well be a factor in the apparent upwards trend of human rabies. Nevertheless, their further analysis suggests that failure to receive PEP is a major factor in the number of human cases in China. The researchers say there is a need for greatly improved availability and timely application of high-quality anti-rabies biologicals, both vaccines and immunoglobulins, for the treatment of human bite victims. Controlling dog rabies through pet vaccination schemes may also play a huge role in reducing the rate of human exposure. Education of the public, health care staff and veterinarians will also help to change the current situation. 2008 Si et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Comments |
Featured Meetings:Is your organisation working against the infectious diseases of poverty? |
There are no comments about this article: Please login if you want to submit a comment.